A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 27, Issue 2, 2010, Pages 121-130

  Xaubet, Antoni ^a,b,c   Fu, W J ^d   Li, M ^d   Serrano Mollar, A ^b,c,e   Ancochea, J ^f   Molina Molina, M ^a,b,c   Rodriguez Becerra, E ^g   Morell, F ^c,h   Rodriguez Arias J M ⁱ   Pereda, J ^b,c   Casanova, A ^f   Molins, L ^j   Picado, C ^a,b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e INST D INVESTIGACIONS B   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^j HOSPITAL CLÍNIC   (Spain)

more..

Author keywords

Cuclooxygenase 2; Genetics; Idiopathic pulmonary fibrosis

Indexed keywords

CYCLOOXYGENASE 2;

ADULT; AGED; ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; IDIOPATHIC DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CYCLOOXYGENASE 2; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78651336426     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-64.
2. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007; 356: 1317-26.
3. Nogee LM, Dunbar AE, Wert SE, Askin F, Hamvas A, Whitsett JAL. A mutation in the surfactant protein C gene is associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573-9.
4. Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur Respir J 2005; 25: 915-27.
5. White ES, Lazar MH, Thannickal VJ. Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 2003; 201: 343-54.
6. Crofford LJ. COX-1 and COX-2 tissue expression: implications and predictions. J Rheumatol 1997: 24 (suppl 49): 15-9.
7. Bonner JC, Rice AB, Ingram JL, et al. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am J Pathol 2002; 161: 459-47.
8. Hodges RJ, Jenkins RG, Wheeler-Jones CP, et al Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E2 production. Am J Pathol 2004; 165: 1663-76.
9. Keerthisingam CB, Jenkins RG, Harrison NK, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001; 158: 1411-22.
10. Wilborn J, Crofford LJ, Burdick MD, Kunkel SL, Strieter RM, Peters-Golden M. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 1995; 95: 1861-68.
11. Xaubet A, Roca-Ferrer J, Pujols L, et al. Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21: 35-42.
12. Kosaka T, Miyata A, Ihara H, et al. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxidase synthase 2. Eur J Biochem 1994; 221: 889-97. (Pubitemid 24146188)
13. Cox DG, Boillot C, Canzian F. Data mining: efficiency of using sequence databases for polymorphism discovery. Hum Mutat 2001; 17: 141-50.
14. Cox DG, Pontes C, Guino E, et al. Polymorphisms in prostaglandin synthase 2 / cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Brit J Cancer 2004; 91: 339-43.
15. Cox DG, Crusius JBA, Peters PHM, Bueno-de-Mesquita H, Pena AS. Canzian F. A haplotype of prostaglandin synthase 2/cyclooxygenase 2 is envolved in the susceptability to inflammatory bowel disease. World J Gastroenterol 2005; 11: 6003-8.
16. Campa D, Zienolddiny S, Maggini V, Skuag V, Haugen A., Canzian FL. Association of a common polymorphism in the cyclooxygenase-2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004; 25: 229-35.
17. Papafili A, Hill MR, Brull DJ. et al. Common promoter variant in cyclooxygenase-2 represses gene expression. Arterioscler Thromb Vasc Biol 2002; 22: 1631-6.
18. Vives J, Ercilla G, Castillo R, Rozman C. A study of the HLA system in the Spanish population. In: Histocompatibility testing. Copenhagen, Munksgaard; 1975; 233-8.
19. ∞,) prediction equations from a Mediterranean population. Am Rev Respir Dis 1990; 140: 1026-32.
20. Roca J, Sanchis J, Agusti-Vidal A, Segarra F, Navajas D, Rodríguez-Roisin R. Spirometric reference values from a Mediterranean population. Bull Eur Physioipathol Respir 1986; 22: 217-24.
21. nd ed. Springer, New York, 2002.
22. Warnes GR. The Genetics Package. R News V3 1 June 2003.
23. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm. J Roy Stat Soc B 1977; 39: 1-38.
24. Cui Y, Fu WJ, Sun K, Romero R, Wu RL. Mapping nucleoide sequences that encode complex binary disease traits with HapMap. Current Genomics 2007; 8: 307-22.
25. Efron R, Tibshirani R. An Introduction to The Bootstrap, Chapman Hall/CRC, New York 1993.
26. Xaubet A, Marin-Arguedas A, Lario S, et al. TGF-beta-1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 431-5.
27. 2 production in normal and fibrotic lung fibroblasts. Am J Respir Cell Mol Biol 2000; 22: 628-34.
28. Petkova DK, Clelland CA, Ronan JE, Ronan JE, Lewis S, Knox AJ. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis. Histopathology 2003; 41: 381-6.
29. Lappi-Blanco E, Kaarteenaho-Wiik R, Maasilta PK, Anttila S, Pääkkö P, Wolff H-J. Cox-2 is widely expressed in epithelium in pulmonary fibrous disorders. Am J Clin Pathol 2006; 126: 717-24.
30. López-Campos JL, Rodríguez-Rodriguez D, Rodriguez-Becerra E, et al. Cyclooxygenase-2 polymorphisms confers susceptibility to sarcoidosis but are not related to prognosis. Resp Med 2009; 103: 427-33.
31. Di Marco S, Hel Z, Lachance C, Furneaux H, Radzioch D. Polymorphism in 3′-untranslated region of TNFα mRNA impairs binding of the post-transcriptional regulatory protein HuR to TNFα mRNA. Nucleic Acids Res 2001; 29; 863-871. (Pubitemid 32162253)
32. Cheng I, Liu X, Plummer SJ, Krumroy LM, Casy G, Witte JSL. COX2 genetic variation a, NSAIDs and advanced cancer risk. Br J Cancer 2007; 97: 557-61.
33. Cox DG, Buring J, Hankinson SE, Hunter DJ. A polymorphism in the 3″untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study. Breast Cancer Res 2007; 9: R3.
34. Lee TS, Jeon YT, Kim JW, et al. Lack of association of the cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphism with risk of cervical cancer in korean population. Ann N Y Acad Sci 2007; 1095: 134-143.
35. López-Campos JL, Rodríguez-Rodriguez D, Rodriguez-Becxerra E, et al. Association of the 3050G>C polymorphism in the cxyclooxygenase-2 gene with systemic sarcodosis. Arch Med Res 2008; 39: 525-30.
36. Sugimoto Y, Narumiga S. Prostaglandin E receptors. J Biol Chem 2007; 282: 11613-7.
37. Hill MR, Papafili A, Bootg L, et al. Functional porstaglandin- endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 2006; 174: 915-22.
38. Suske G. The Sp-family of transcription factors. Gene 1999; 238: 291-300.